Literature DB >> 19649383

[Evaluation of the Neonatal Screening Program for congenital hypothyroidism and phenylketonuria in the State of Mato Grosso, Brazil].

Inês Stranieri1, Olga Akiko Takano.   

Abstract

OBJECTIVE: To evaluate the Reference Center for Neonatal Screening for congenital hypothyroidism and phenylketonuria for the State of Mato Grosso.
METHOD: Cross-sectional study using secondary data of screening tests carried out from January 2003 to December 2004.
RESULTS: 66,337 exams were conducted with population coverage of less than 70%. The prevalence of phenylketonuria was 1:33,068 live births and of congenital hypothyroidism was 1:9,448 live births. Only 22% of the samples were collected at the recommended ag, and most of the samples were collected between the ages of 8 and 30 days. The median age at collection was 12 days. It was observed that the service had difficulties in recalling suspected cases and financial difficulties in obtaining laboratorial reagents.
CONCLUSIONS: The age at the time of collection and the delay at the diagnostic confirmation stage were the principal reasons for the delay in the initiation of treatment of the cases detected by the service.

Entities:  

Mesh:

Year:  2009        PMID: 19649383     DOI: 10.1590/s0004-27302009000400010

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  6 in total

1.  IDENTIFICATION OF MUTATIONS IN THE PAH GENE IN PKU PATIENTS IN THE STATE OF MATO GROSSO.

Authors:  Roseli Divino Costa; Bianca Borsatto Galera; Bianca Costa Rezende; Amanda Cristina Venâncio; Marcial Francis Galera
Journal:  Rev Paul Pediatr       Date:  2020-02-14

2.  Burden of phenylketonuria in Latin American patients: a systematic review and meta-analysis of observational studies.

Authors:  A L S Pessoa; A M Martins; E M Ribeiro; N Specola; A Chiesa; D Vilela; E Jurecki; D Mesojedovas; I V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2022-07-30       Impact factor: 4.303

3.  Genetics and genomics in Brazil: a promising future.

Authors:  Maria Rita Passos-Bueno; Debora Bertola; Dafne Dain Gandelman Horovitz; Victor Evangelista de Faria Ferraz; Luciano Abreu Brito
Journal:  Mol Genet Genomic Med       Date:  2014-07       Impact factor: 2.183

4.  Follow-up of children with hemoglobinopathies diagnosed by the Brazilian Neonatal Screening Program in the State of Pernambuco.

Authors:  Ana Caroline Novaes Soares; Isabella Chagas Samico; Aderson Silva Araújo; Marcos André C Bezerra; Betânia Lucena Domingues Hatzlhofer
Journal:  Rev Bras Hematol Hemoter       Date:  2014-05-28

5.  Challenges of Implementation of the National Phenylketonuria Screening Program in Iran: A Qualitative Study.

Authors:  Alireza Heidari; Mohammad Arab; Koorosh Etemad; Behzad Damari; Mohammad Javad Kabir
Journal:  Electron Physician       Date:  2016-10-25

6.  Quality of life and adherence to treatment in early-treated Brazilian phenylketonuria pediatric patients.

Authors:  E Vieira; H S Maia; C B Monteiro; L M Carvalho; T Tonon; A P Vanz; I V D Schwartz; M G Ribeiro
Journal:  Braz J Med Biol Res       Date:  2017-12-11       Impact factor: 2.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.